REVB

REVELATION BIOSCIENCES, INC.

Nasdaq · Pharmaceutical Preparations · Inc. DE · CIK 0001810560
$0.9900 -6.16% $3.9M
Vol
Market Cap$3.9M
Cap SizeNano Cap
Exchange Nasdaq·Sector Pharmaceutical Preparations·Inc. DE·CIK 0001810560·Prev Close $1.05

Recent Activity

May 6, 2026 earnings_calendar
REVB Q1 2026 Earnings Scheduled — 2026-05-06
Apr 30, 2026 Insider
Rolke James sold 10,115 shares
Chief Executive Officer @ $1.13 ($11.4K)
Apr 30, 2026 Insider
Zygmont Chester Stanley III sold 13,285 shares
Chief Financial Officer @ $1.10 ($14.6K)
Feb 4, 2026 Insider
Zygmont Chester Stanley III sold 13,100 shares
Chief Financial Officer @ $1.65 ($21.6K)

Price Targets

No recent covering-analyst activity on file. No current recommendation available.
$19.25
Current $0.9900 Low $16.00 Median $19.25 High $22.50 2 analysts
$16.00 $22.50

Analyst Ratings

Historical distribution86% buy · 7 analysts · no recent coverage
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Current Q $-0.83 ▲ +19.8% $-0.88 — $-0.78 97% YoY 2
Next Q $-0.81 ▲ +19.9% $-0.83 — $-0.78 89% YoY 2
Current FY $-5.00 ▼ -20.2% $-5.20 — $-4.79 79% YoY 2
Next FY $-2.77 ▲ +15.8% $-2.99 — $-2.56 44% YoY 2

Recent Insider Trades

DateInsiderTypeValue
Apr 30, 2026Rolke JamesF$11.4K
Apr 30, 2026Zygmont ChesterF$14.6K
Feb 4, 2026Zygmont ChesterF$21.6K
Feb 3, 2026Chawla LakhmirF$4.2K
Feb 3, 2026ROPER JESSF$2.9K

No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.

5 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
Apr 30, 2026Rolke JamesChief Executive OfficerF10,115$1.13$11.4K
Apr 30, 2026Zygmont Chester Stanley IIIChief Financial OfficerF13,285$1.10$14.6K
Feb 4, 2026Zygmont Chester Stanley IIIChief Financial OfficerF13,100$1.65$21.6K
Feb 3, 2026Chawla Lakhmir SDirectorF2,261$1.85$4.2K
Feb 3, 2026ROPER JESSDirectorF1,591$1.85$2.9K
Feb 3, 2026CARVER JENNIFERDirectorF1,661$1.87$3.1K
Feb 3, 2026Rolke JamesChief Executive OfficerF8,521$1.86$15.8K

No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Historical analyst distribution: 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.

Analyst Price Targets

No recent covering-analyst activity on file. No current recommendation available.
$19.25 mean target
$16.00 Low $22.50 High
MetricValue
Current Price$0.9900
Target Low$16.00
Target Mean$19.25
Target Median$19.25
Target High$22.50
# Analysts2
Recommendation— (no recent coverage)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-06-30
$-0.83 $-0.88 $-0.78 97.0% +19.8% $0.0B 0.0% 2
Next Q
2026-09-30
$-0.81 $-0.83 $-0.78 88.6% +19.9% $0.0B 0.0% 2
Current FY
2026-12-31
$-5.00 $-5.20 $-4.79 79.1% -20.2% 1↑ 0↓ $0.0B 0.0% 2
Next FY
2027-12-31
$-2.77 $-2.99 $-2.56 44.4% +15.8% 1↑ 0↓ $0.0B 0.0% 2

Current Quarter EPS Revision History

TimepointEPS EstimateChange
Current$-0.830
7d ago$-1.035+0.205
30d ago$-1.035+0.205
60d ago$-1.035+0.205
90d ago$-4.600+3.770

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 20262410086%
May 1, 20262410086%
Apr 1, 20262410086%
Mar 1, 20262410086%
Feb 1, 20262410086%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

May 6, 2026
earnings_calendar
REVB Q1 2026 Earnings Scheduled — 2026-05-06
Mar 4, 2026
earnings_calendar
REVB Q4 2025 Earnings After Market Close — 2026-03-04